Brainstorm Cell TherapeuticsBCLI
13F holders, Q1 2025 (March 31)32holders +1
7new positions
6sold out
$1.07avg. 13F price*
At the end of Q1 2025, 32 institutions reported holding Brainstorm Cell Therapeutics (BCLI) in their 13F filings, up 1 from Q4 2024. 7 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($870K), Geode Capital Management, LLC ($73K) and Vanguard Group Inc. ($35K).
- Company
- Brainstorm Cell Therapeutics
- CUSIP
- 10501E300
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $919K |
| Exits | 6 | $65K |
All 13F filers, Q4 2024 → Q1 2025: 740,576 shares bought and 83,177 shares sold, net +657,399 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 32 holders
| Armistice Capital, LLC | 0.02% | New | 690,666 | $870K |
| Geode Capital Management, LLC | 0.00% | Add +10.8% | 58,165 | $73K |
| Vanguard Group Inc. | 0.00% | Reduce -64.7% | 27,724 | $35K |
| BlackRock, Inc. | 0.00% | No change | 25,172 | $32K |
| Liberty Wealth Management LLC | 0.01% | New | 22,666 | $29K |
| Two Sigma Securities, LLC | 0.00% | Add +43.0% | 16,153 | $20K |
| Weaver Consulting Group | 0.01% | New | 15,623 | $20K |
| Morgan Stanley | 0.00% | Add +0.5% | 4,338 | $5K |
| Osaic Holdings, Inc. | 0.00% | Reduce -10.2% | 1,719 | $2K |
| Wells Fargo & Company | 0.00% | No change | 1,338 | $2K |
| Activest Wealth Management | 0.00% | No change | 334 | $421 |
| Bangor Savings Bank | 0.00% | New | 266 | $335 |
| UBS Group AG | 0.00% | Reduce -92.7% | 253 | $319 |
| FMR LLC | 0.00% | Add +109.9% | 233 | $294 |
| SBI Securities Co., Ltd. | 0.00% | Add +31.7% | 220 | $277 |
| Jones Financial Companies LLLP | 0.00% | New | 216 | $257 |
| JPMorgan Chase & Co. | 0.00% | Add +3320.0% | 171 | $215 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 135 | $170 |
| VSM Wealth Advisory, LLC | 0.00% | New | 120 | $151 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 113 | $142 |
| Bank of America Corp. | 0.00% | Add +4.7% | 111 | $140 |
| Clearstead Advisors, LLC | 0.00% | No change | 100 | $126 |
| Cranbrook Wealth Management, LLC | 0.00% | No change | 66 | $84 |
| St Germain D J Co. Inc. | 0.00% | No change | 33 | $42 |
| BNP Paribas Financial Markets | 0.00% | No change | 24 | $30 |
| Centricity Wealth Management, LLC | 0.00% | No change | 20 | $25 |
| Westside Investment Management, Inc. | 0.00% | No change | 12 | $16 |
| CBIZ Investment Advisory Services, LLC | 0.00% | No change | 13 | $16 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 10 | $13 |
| CoreCap Advisors, LLC | 0.00% | No change | 8 | $10 |
| Bogart Wealth, LLC | 0.00% | No change | 2 | $3 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 157,009 | $0 |
"% of holder's portfolio" is BCLI's weight in each manager's 13F, not the share of Brainstorm Cell Therapeutics the manager owns.